Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Study: Treatment of Relapsed Lymphoid Malignancies With an Anti-Angiogenic Approach
This study is ongoing, but not recruiting participants.
Study NCT00250718 Information provided by New Mexico Cancer Care Alliance
First Received on November 4, 2005. Last Updated on February 18, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Non-Hodgkin's Lymphoma
Cancer
Additional conditions recognized in this trial
Lymphoma
Lymphoma, Non-Hodgkin
Neoplasms
More general conditions related to this trial
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoproliferative Disorders
Neoplasms by Histologic Type
Interventions listed in this trial
Vincristine
VP-16
Rituximab
Dexamethasone
Levofloxacin
Additional drug interventions recognized in this trial
Angiogenesis Inhibitors
BB 1101
Dexamethasone 21-phosphate
Dexamethasone acetate
Etoposide
Ofloxacin
More general drug interventions related to this trial
Angiogenesis Modulating Agents
Anti-Bacterial Agents
Anti-Infective Agents
Anti-Infective Agents, Urinary
Anti-Inflammatory Agents
Antiemetics
Antimitotic Agents
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Antineoplastic Agents, Phytogenic
Antirheumatic Agents
Autonomic Agents
Central Nervous System Agents
Enzyme Inhibitors
Gastrointestinal Agents
Glucocorticoids
Growth Inhibitors
Growth Substances
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Immunologic Factors
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Nucleic Acid Synthesis Inhibitors
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protease Inhibitors
Renal Agents
Therapeutic Uses
Tubulin Modulators
Sponsors listed in this trial
New Mexico Cancer Care Alliance
Back to top of Main Content